Personalized Cancer Treatment

Åslaug Helland, Senior Oncologist and Head of Research at Oslo University Hospital, with Silvija Seres at LørnTech.

What is DNA-sequencing and how does science meet today's technology? In this episode, Åslaug and Silvija discuss gene sequencing at OUH and the commitment to develop new and better methods to further precise diagnostics that will facilitate personalized treatment.

Follow this link to listen to the podcast!


Learnings from the episode

  • Cancer treatment
  • Diagnostics
  • Lung cancer
  • DNA-sequencing
  • Age-related diseases

 This article is from an episode of #Lørn, made in collaboration with LørnTech.  

   

Quick Q and A with Åslaug 

Title and company:
Senior Oncologist at OUH and Head of Research at the Cancer Clinic.   

Education?
Doctor of medicine.  

SoMe tag? 
@HellandAslaug 

Who are you and how did you get into innovation in health?
I am a Senior Oncologist who works with lung cancer at OUH. Moreover, I have always worked with research and was recently constituted as Head of Research at the Cancer Clinic. From what I have seen, there is a need for innovation to solve challenges and bottlenecks within public health care. I am all for a great public health care. A health care in which everyone can benefit from that parties can act as spearheads in their own professional field.

" ... there is a need for innovation to solve challenges and bottlenecks within public health care. "

What is the main problem that you are trying to solve at your place of work?
Luckily, we have more possibilities today compared to what we had in the past. Lung cancer belongs to a professional field that has taken part in a development. In the past, there was little to provide or offer patients with lung cancer. It was all about discovering the cancer as late as possible because there was nothing we could do for the patients. Today, more options are available in regards to diagnostic processes and treatments. The options are costly and includes diagnostics, treatments with cancer drugs, radiation, and follow-up care.

What is your focus within technology and main project at the moment?
Diagnostics is the core of being able to personalize treatment. Hence, we will have to sequence and join in on developing good methods for precise diagnostics. 

Why do you find this exciting?
This can help a large number of patients with many diseases. We also observe upcoming developments within our professional field, which does not only concern gene sequencing, as it includes how Artificial Intelligence (AI) and several layers of information can be utilized to tailor treatments for each patient.   

What dilemmas do you find interesting within your professional field?
There is a lot of focus on costs within public health care. The most expensive treatment is the one that does not work, which applies both to patients and society alike. Large investments are also needed for new technology, which in turn could save resources over time, like if we were to introduce AI into uncomplicated services provided within radiology and pathology. 

" The most expensive treatment is the one that does not work, which applies both to patients and society alike. "

Other important projects of yours over the last year?
Clinical studies and traditional, clinical research.

What do we do uniquely well in Norway related to your professional field?
We have a great public health care and a number of unbelievably skilled professionals. 

What do you think is the most relevant knowledge for the future?
Knowledge and technology related to specific tasks and needs.

Recommended literature / videos about your professional field?
Nature, published in 2019. Follow this link.

The most important point from our conversation?
We need new technology to solve our tasks!


Food for Thought

The goal is to create personalized treatment, as well as to eliminate the treatment that does not work. In which way is it crucial that doctors and health care personnel collaborates across different areas to ensure the rapid, forward progress in the medical development? How can the nurse contribute to developments in the laboratory at the hands of the scientist?

" The goal is to create personalized treatment, as well as to eliminate the treatment that does not work. "


Åslaug Helland

Senior Oncologist and Head of Research at the Cancer Clinic

Oslo University Hospital

Send email

Relevant Projects

Extraction of text from health records with NLP and ML

Extraction of text from health records with NLP and ML

This project began with the ambitious aim of reducing the workload for clinicians treating patients with colorectal cancer.
Illustrating scans of the urinary tract

ProtehCT

Prospective Trial for Examining Hematuria using Computed Tomography (PROTEHCT) is a prospective clinical trial at Oslo University Hospital, Aker. Division of Radiology and Nuclear medicine. The primary objective is to evaluate whether
Comprehensive clinical report from molecular diagnostics in cancer

Comprehensive clinical report from molecular diagnostics in cancer

Cancer is a genetic disease, as DNA is altered in each tumor. The changes differ greatly between different tumors and over time in a tumor. Many changes can occur in each tumor, and these changes may represent targets for therapy, or serve